Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146968
Max Phase: Preclinical
Molecular Formula: C67H102N14O10
Molecular Weight: 1263.64
Molecule Type: Small molecule
Associated Items:
ID: ALA2146968
Max Phase: Preclinical
Molecular Formula: C67H102N14O10
Molecular Weight: 1263.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCN)NC(=O)[C@H](CC23CC4CC(CC(C4)C2)C3)NC(=O)[C@H](CCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCN)NC1=O
Standard InChI: InChI=1S/C67H102N14O10/c1-41(2)31-51-61(86)72-47(19-9-25-68)58(83)77-52(35-42-15-5-3-6-16-42)65(90)81-30-14-24-56(81)64(89)75-50(22-12-28-71)60(85)79-54(40-67-37-44-32-45(38-67)34-46(33-44)39-67)62(87)73-48(20-10-26-69)59(84)78-53(36-43-17-7-4-8-18-43)66(91)80-29-13-23-55(80)63(88)74-49(21-11-27-70)57(82)76-51/h3-8,15-18,41,44-56H,9-14,19-40,68-71H2,1-2H3,(H,72,86)(H,73,87)(H,74,88)(H,75,89)(H,76,82)(H,77,83)(H,78,84)(H,79,85)/t44?,45?,46?,47-,48-,49-,50-,51-,52+,53+,54-,55-,56-,67?/m0/s1
Standard InChI Key: NCRWPDBHZHBEQH-IXMVRCTNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1263.64 | Molecular Weight (Monoisotopic): 1262.7903 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kapoerchan VV, Knijnenburg AD, Keizer P, Spalburg E, de Neeling AJ, Mars-Groenendijk RH, Noort D, Otero JM, Llamas-Saiz AL, van Raaij MJ, van der Marel GA, Overkleeft HS, Overhand M.. (2012) 'Inverted' analogs of the antibiotic gramicidin S with an improved biological profile., 20 (20): [PMID:22989907] [10.1016/j.bmc.2012.08.038] |
Source(1):